IRIDEX Corporation (IRIX)
0.97
0.18 (22.77%)
At close: Mar 21, 2025, 3:59 PM
0.97
0.09%
After-hours: Mar 21, 2025, 06:30 PM EDT
22.77% (1D)
| Bid | 0.87 |
| Market Cap | 16.06M |
| Revenue (ttm) | 48.59M |
| Net Income (ttm) | -11.07M |
| EPS (ttm) | -0.67 |
| PE Ratio (ttm) | -1.44 |
| Forward PE | -6.15 |
| Analyst | Hold |
| Ask | 1 |
| Volume | 157,590 |
| Avg. Volume (20D) | 58,564 |
| Open | 0.90 |
| Previous Close | 0.79 |
| Day's Range | 0.80 - 1.06 |
| 52-Week Range | 0.78 - 3.65 |
| Beta | 0.94 |
About IRIX
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuL...
Industry Medical - Devices
Sector Healthcare
IPO Date Feb 16, 1996
Employees 111
Stock Exchange NASDAQ
Ticker Symbol IRIX
Website https://www.iridex.com
Analyst Forecast
According to 1 analyst ratings, the average rating for IRIX stock is "Hold." The 12-month stock price forecast is $2, which is an increase of 107.23% from the latest price.
Stock ForecastsNext Earnings Release
IRIDEX Corporation is scheduled to release its earnings on Mar 27, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+34.04%
IRIDEX shares are trading higher. The company repo...
Unlock content with
Pro Subscription
10 months ago
-13.96%
IRIDEX shares are trading lower after the company reported worse-than-expected Q1 financial results.
